Arkolith/Insider Trading/DALS/Form 4

Section 32 Fund 3, LP

Director, 10% OwnerDA32 Life Science Tech Acquisition Corp. (DALS) · full profile →Form 4 · filed Aug 9, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 5, 2021Disposed to issuer(D)701K—$04.7M
Aug 5, 2021Disposed to issuer(D)30K—$04.7M

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-032284) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML